216 related articles for article (PubMed ID: 35201950)
21. Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report.
Koyama M; Nishijima E; Honda T; Gonmori-Ohta C; Sasamoto T; Tanaka K; Watanabe A; Nakano T; Akiyama M
BMC Ophthalmol; 2024 Mar; 24(1):115. PubMed ID: 38481205
[TBL] [Abstract][Full Text] [Related]
22. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
Kikuchi R; Kawagoe T; Hotta K
BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
[TBL] [Abstract][Full Text] [Related]
23. Rituximab for sight-threatening refractory pediatric Vogt-Koyanagi-Harada disease.
Umran RMR; Shukur ZYH
Mod Rheumatol; 2018 Jan; 28(1):197-199. PubMed ID: 26154298
[TBL] [Abstract][Full Text] [Related]
24. Harada-like syndrome post-Covishield vaccination: A rare adverse effect.
Reddy Y; Pandey A; Ojha A; Ramchandani S
Indian J Ophthalmol; 2022 Jan; 70(1):321-323. PubMed ID: 34937269
[TBL] [Abstract][Full Text] [Related]
25. EFFICACY OF COMBINED SYSTEMIC CORTICOSTEROID AND EARLY IMMUNOMODULATORY THERAPY WITHIN THREE MONTHS OF ONSET IN VOGT-KOYANAGI-HARADA DISEASE.
Park HS; Park HY; Lee CS; Lee SC; Lee JH
Retina; 2022 Dec; 42(12):2361-2367. PubMed ID: 36394890
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Alromaih AZ; Almater AI; Albloushi AF; Alkheraiji NF; Abu El-Asrar AM
Int Ophthalmol; 2023 Jan; 43(1):185-195. PubMed ID: 35945413
[TBL] [Abstract][Full Text] [Related]
27. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
Herbort CP; Mantovani A; Bouchenaki N
Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
[TBL] [Abstract][Full Text] [Related]
28. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
[TBL] [Abstract][Full Text] [Related]
29. Cytomegalovirus retinitis following corticosteroid overdose for Vogt-Koyanagi-Harada disease.
Khochtali S; Mahjoub A; Dridi T; Ksiaa I; Abroug N; Khairallah M
Indian J Ophthalmol; 2020 Sep; 68(9):2012-2014. PubMed ID: 32823462
[TBL] [Abstract][Full Text] [Related]
30. A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma.
Brambati M; Giuffrè C; Marchese A; Bandello F; Modorati GM; Miserocchi E
Eur J Ophthalmol; 2022 Jan; 32(1):NP109-NP113. PubMed ID: 32998540
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of B Cell Depletion Therapy with Rituximab in Refractory Chronic Recurrent Uveitis Associated with Vogt-Koyanagi-Harada Disease.
Abu El-Asrar AM; Dheyab A; Khatib D; Struyf S; Van Damme J; Opdenakker G
Ocul Immunol Inflamm; 2022 Apr; 30(3):750-757. PubMed ID: 32990482
[TBL] [Abstract][Full Text] [Related]
32. Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine.
Sato T; Nihei R; Sora D; Nishio Y; Takeuchi M
Front Immunol; 2022; 13():967972. PubMed ID: 36248859
[TBL] [Abstract][Full Text] [Related]
33. Posterior segment recurrences in Vogt-Koyanagi-Harada disease.
Sachdev N; Gupta V; Gupta A; Singh R
Int Ophthalmol; 2008 Oct; 28(5):339-45. PubMed ID: 17898934
[TBL] [Abstract][Full Text] [Related]
34. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
35. [Vogt Koyanagi Harada syndrome in children: diagnosis and management].
Benfdil N; Baha Ali T; Jellab B; Moutaouakil A
Bull Soc Belge Ophtalmol; 2010; (314):15-8. PubMed ID: 20480746
[TBL] [Abstract][Full Text] [Related]
36. Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study.
Ingolotti M; Schlaen BA; Roig Melo-Granados EA; Ruiz García H; Aguilera Partida JA
Am J Case Rep; 2019 Mar; 20():300-305. PubMed ID: 30842390
[TBL] [Abstract][Full Text] [Related]
37. Vogt-Koyanagi-Harada Disease and COVID.
Manni P; Saturno MC; Accorinti M
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834885
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of patients with acute Vogt-Koyanagi-Harada disease treated with intravenous corticosteroid pulse followed by the slow tapering of oral corticosteroid therapy.
Fushitsu R; Ishibazawa A; Murono M; Kinouchi R
Int Ophthalmol; 2023 Feb; 43(2):431-440. PubMed ID: 35869402
[TBL] [Abstract][Full Text] [Related]
39. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
[TBL] [Abstract][Full Text] [Related]
40. Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature.
Duan J; Wang Y; Liu D; Ma J
Ocul Immunol Inflamm; 2019; 27(2):229-234. PubMed ID: 29023176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
